Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.

Received from

Pending at the end of last month

Received

Resolved*

Total Pending #

Pending complaints >3months

Average Resolution time^ (in days)

Directly from Investors

SEBI (SCORES)

Other Sources (if any)

Grand Total

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.

Month

Carried forward from previous month

Received

Resolved*

Pending#

Jun, 2026

Jul, 2026

Aug, 2026

Grand Total

Sr. No.	Fin. Year	Received	Resolved*
1	2022-23	1	1
2	2023-24	0	0
3	2024-25	0	0
4	2025-26	1	1
	Grand Total	2	2

Sr. No.

Fin. Year

Carried forward from previous year

Received

Resolved*

Pending#

2022-23

2023-24

2024-25

2025-26

Grand Total

Nifty Healthcare Index Companies

BSE Sensex 73123.83 125.56 (-0.17%)

See MoneyWorks4me's rating on Quality, Valuation, Price Trend and Overall Rating to take informed stock investing decisions. Decizen :- Q: Quality, V: Valuation, PT: Price Trend

Filter

Nifty Healthcare Index companies as on Oct-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	CMP	Price Change (%)	Market Cap (Cr)	52Week High	52Week Low	ROE(%)	P/E	P/BV	EV/ EBITDA	5Y Sales Gr.(%)	5Y Profit Gr.(%)
checkbox 124494 1	Ipca Laboratories Ltd	Q V+ PT	1,951	2.55%	48,274 Mid Cap	2,039 22 Sep, 26	1,253 24 Oct, 25	16.05	38.81	5.78	23.62	7.35	1.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
checkbox 108869 2	Apollo Hospitals Enterprise Ltd	Q V PT	7,732	1.87%	1,09,133 Large Cap	9,327 03 Aug, 26	6,680 28 Jan, 26	16.08	69.47	10.58	39.16	14.92	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
checkbox 100087 3	Cipla Ltd	Q V PT	1,337	0.53%	1,07,439 Large Cap	1,672 23 Oct, 25	1,166 02 Apr, 26	11.57	31.87	3.06	17.23	8.01	10.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
checkbox 218071 4	Max Healthcare Institute Ltd	Q V PT	817	0.44%	79,169 Mid Cap	1,221 23 Oct, 25	797 22 Oct, 26	14.68	54.34	7.24	32.75	27.27	155.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
checkbox 100257 5	Lupin Ltd	Q V PT	1,925	-0.16%	88,166 Mid Cap	2,530 16 Jul, 26	1,897 22 Oct, 26	26.43	15.95	3.70	8.83	13.02	32.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
checkbox 221645 6	Krishna Institute of Medical Sciences Ltd	Q V PT	666	-0.52%	28,124 Small Cap	858 06 Jul, 26	576 27 Jan, 26	11.38	137.66	7.43	36.04	24.04	3.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
checkbox 132843 7	Fortis Healthcare Ltd	Q V+ PT	720	-0.55%	54,659 Mid Cap	1,101 23 Oct, 25	711 22 Oct, 26	11.22	52.16	5.38	26.13	17.76	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
checkbox 124715 8	Sun Pharmaceutical Industries Ltd	Q V PT	1,743	-0.62%	4,20,831 Large Cap	2,048 31 Jul, 26	1,584 29 Jan, 26	14.80	34.79	4.87	20.58	11.78	14.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
checkbox 132321 9	Zydus Lifesciences Ltd	Q V PT	1,128	-0.63%	1,13,217 Mid Cap	1,232 29 Sep, 26	836 02 Apr, 26	17.64	25.09	4.20	14.08	13.52	14.72	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
checkbox 132523 10	Biocon Ltd	Q V PT	327	-0.96%	53,739 Mid Cap	447 16 Jul, 26	329 22 Oct, 26	0.71	550.04	1.96	92.96	2.96	-18.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
checkbox 100124 11	Dr. Reddys Laboratories Ltd	Q V PT	1,225	-1.17%	1,03,417 Mid Cap	1,414 29 Jun, 26	1,080 23 Jul, 26	10.90	32.10	2.71	16.43	12.09	15.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
checkbox 235355 12	Gland Pharma Ltd	Q V PT	2,825	-1.17%	47,172 Mid Cap	3,171 07 Oct, 26	1,575 16 Mar, 26	10.05	41.79	4.44	21.27	13.18	0.09	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
checkbox 271867 13	Laurus Labs Ltd	Q V+ PT	1,974	-1.20%	1,07,954 Mid Cap	2,087 19 Oct, 26	902 24 Oct, 25	17.86	98.74	19.14	52.81	7.19	-2.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
checkbox 212427 14	Alkem Laboratories Ltd	Q V PT	4,920	-1.26%	59,577 Mid Cap	5,933 13 Jan, 26	4,880 22 Oct, 26	18.04	27.61	4.16	16.37	10.66	8.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
checkbox 132488 15	Divis Laboratories Ltd	Q V+ PT	8,984	-1.48%	2,42,074 Large Cap	10,000 10 Sep, 26	5,648 02 Apr, 26	15.58	82.76	13.71	54.01	8.67	4.44	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
checkbox 100488 16	Abbott India Ltd	Q V PT	25,004	-1.53%	53,959 Mid Cap	30,598 25 Nov, 25	25,141 11 Sep, 26	34.24	33.42	10.42	22.88	9.96	17.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
checkbox 132296 17	Glenmark Pharmaceuticals Ltd	Q V+ PT	2,130	-2.45%	61,612 Mid Cap	2,537 28 Aug, 26	1,794 28 Oct, 25	27.89	34.27	5.62	11.41	9.19	22.19	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
checkbox 211840 18	Mankind Pharma Ltd	Q V PT	2,217	-2.63%	94,042 Mid Cap	2,640 29 Jul, 26	1,910 23 Mar, 26	12.76	46.04	5.59	23.99	18.10	8.40	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
checkbox 100420 19	Torrent Pharmaceuticals Ltd	Q V+ PT	4,482	-2.78%	1,75,355 Large Cap	5,250 03 Aug, 26	3,533 06 Nov, 25	29.04	80.40	19.54	36.90	11.80	13.74	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
checkbox 124804 20	Aurobindo Pharma Ltd	Q V+ PT	1,569	-3.49%	93,556 Mid Cap	1,740 05 Oct, 26	1,080 24 Oct, 25	10.64	36.08	3.99	24.87	-6.73	-4.90	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Nifty Healthcare Index - Today's Top Gainers

Company Name	CMP	Price Change(%)
Ipca Laboratories	1,951.25	2.55%
Apollo Hospital Ent.	7,731.95	1.87%
Cipla	1,337	0.53%
Max Healthcare Inst.	817	0.44%

Nifty Healthcare Index - Today's Top Losers

Company Name	CMP	Price Change(%)
Aurobindo Pharma	1,569.30	-3.49%
Torrent Pharma	4,482	-2.78%
Mankind Pharma	2,217	-2.63%
Glenmark Pharma.	2,129.60	-2.45%
Abbott India	25,004.30	-1.53%

News about Nifty Healthcare Index

Oct, 2026

Glenmark Pharmaceuticals submits board meeting intimation

Glenmark Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on Thursday, November 5, 2026, to consider and approve the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026. Further noted that the notice of the aforesaid meeting is also being made available on the website of the Company in terms of Regulation 46(2) of the SEBI LODR. The Unaudited Financial Results of the Company shall be submitted to the Stock Exchanges after the conclusion of the aforesaid Board Meeting on Thursday, November 5, 2026, and will also be hosted on the website of the Company on the said date and thereafter shall be published in the newspapers, in accordance with the SEBI LODR. Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, and Company’s Code of Conduct for Prevention of Insider Trading, the Company has already informed the Stock Exchanges vide its letter dated September 28, 2026 that the window for trading in securities of the Company for the Designated Persons viz, Directors, Key Managerial Personnel, Identified Employees / Persons of the Company including the Immediate Relatives of the Designated Persons and the Connected Persons, etc. would remain closed from October 01, 2026 till the expiry of 48 hours after the declaration of Unaudited Financial results for the quarter and half year ended September 30, 2026 and accordingly, the trading window shall remain closed till Saturday, November 07, 2026 and shall re-open thereafter, i.e. on Sunday, November 08, 2026.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

USFDA completes cGMP inspection at Cipla’s arm’s New York facility

The inspection concluded with zero Form 483 observations

Oct, 2026

Cipla informs about updates

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Cipla has informed that an inspection was conducted by the United States Food and Drug Administration (USFDA) at the manufacturing facility of InvaGen Pharmaceuticals Inc. (InvaGen) (wholly owned subsidiary of the Company) located in Hauppauge, Long Island, New York, USA from 19th October, 2026 to 22nd October 2026 (ET). The Inspection was a routine current Good Manufacturing Practices (cGMP) Inspection. The inspection concluded with zero Form 483 observations.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Ipca Laboratories informs about board meeting

Ipca Laboratories has informed that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 consider and approve Standalone and Consolidated Unaudited Financial Results for the second quarter and half year ended 30.09.2026,

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Zydus Lifesciences rises as its arm partners with Prolific Machines

Zylidac will first complete a tech transfer of Prolific's process at 50- liter scale to reproduce Prolific's results at the Zylidac site

Oct, 2026

Zydus Lifesciences’ arm partners with Prolific Machines

Zylidac will first complete a tech transfer of Prolific's process at 50- liter scale to reproduce Prolific's results at the Zylidac site

Track Now:

5 Star Companies Large Cap Companies Mid Cap Companies Small Cap Companies Nifty Microcap Companies Top IT Companies Tax saver funds Analyze your Equity Funds Nifty Index Funds

All Indices

Broad Based Indices:

Nifty 50 Nifty Next 50 Nifty 100 Nifty 200 Nifty Total Market Nifty 500 Nifty Midcap 150 Nifty Midcap 50 Nifty Midcap Select Nifty Midcap 100 Nifty Smallcap 250 Nifty Smallcap 50 NIFTY Smallcap 100 Nifty Microcap 250 Nifty Largemidcap 250 Nifty500 Multicap 50:25:25

Sectoral Indices:

Nifty Auto Nifty Bank Nifty Healthcare Nifty IT Nifty Financial Services Nifty Media Nifty Metal Nifty Pharma Nifty Private Bank Nifty PSU Bank Nifty Realty Nifty Consumer Durables Nifty Oil & Gas Nifty Financial Services 25/50 Nifty Financial Services Ex Bank Nifty FMCG

Thematic Indices:

Nifty Aditya Birla Group Nifty Core Housing Nifty Commodities Nifty CPSE Nifty Financial Services Nifty Energy Nifty Housing Nifty India Consumption Nifty India Defence Nifty India Digital Nifty India Manufacturing Nifty Infrastructure Nifty Mahindra Group Nifty Midcap Liquid 15 Nifty MNC Nifty Mobility Nifty PSE Nifty Non-cyclical Consumer Nifty Services Sector Nifty Shariah 25 Nifty Tata Group Nifty Tata Group 25% Cap Nifty Transportation & Logistics Nifty100 Liquid 15 Nifty50 Shariah Nifty500 Shariah NIFTY SME EMERGE Nifty100 Esg NIFTY100 Enhanced ESG Nifty100 ESG Sector Leaders

Strategy Indices:

Nifty100 Equal Weight Nifty100 Low Volatility 30 Nifty 50 Arbitrage Nifty200 Momentum 30 NIFTY100 Alpha 30 Nifty Alpha 50 Nifty Alpha Low-volatility 30 Nifty Alpha Quality Low-volatility 30 Nifty Alpha Quality Value Low-volatility 30 Nifty Growth Sectors 15 Nifty High Beta 50 NIFTY100 Quality 30 NIFTY Midcap150 Quality 50 Nifty Quality Low Volatility 30 Nifty50 Dividend Points Nifty50 Equal Weight Nifty50 Value 20 Nifty500 Value 50 Nifty200 Quality 30

Nifty Healthcare Index FAQs

You can use different criterias to arrive at the list of best stocks in the Nifty Healthcare Index company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Healthcare Index companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,004	53,959	33.42	10.42	22.88	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,482	1,75,355	80.40	19.54	36.90	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,130	61,612	34.27	5.62	11.41	27.89
Lupin Ltd. (M)	Somewhat Good	1,925	88,166	15.95	3.70	8.83	26.43
Alkem Laboratories Ltd. (M)	Very Good	4,920	59,577	27.61	4.16	16.37	18.04

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,974	1,07,954	116
Gland Pharma Ltd. (M)	Very Good	2,825	47,172	48.55
Ipca Laboratories Ltd. (M)	Very Good	1,951	48,274	48.47
Aurobindo Pharma Ltd. (M)	Very Good	1,569	93,556	47.68
Divis Laboratories Ltd. (L)	Very Good	8,984	2,42,074	38.30
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Max Healthcare Institute Ltd. (M)	N/A	817	79,169	54.34	7.24	32.75	27.27
Krishna Institute of Medical Sciences Ltd. (S)	Very Good	666	28,124	138	7.43	36.04	24.04
Mankind Pharma Ltd. (M)	Very Good	2,217	94,042	46.04	5.59	23.99	18.10
Fortis Healthcare Ltd. (M)	Very Good	720	54,659	52.16	5.38	26.13	17.76
Apollo Hospitals Enterprise Ltd. (L)	Somewhat Good	7,732	1,09,133	69.47	10.58	39.16	14.92

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Max Healthcare Institute Ltd. (M)	N/A	817	79,169	54.34	7.24	32.75	155
Lupin Ltd. (M)	Somewhat Good	1,925	88,166	15.95	3.70	8.83	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,130	61,612	34.27	5.62	11.41	22.19
Abbott India Ltd. (M)	Very Good	25,004	53,959	33.42	10.42	22.88	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,225	1,03,417	32.10	2.71	16.43	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Nifty Healthcare Index Companies

News about Nifty Healthcare Index

Glenmark Pharmaceuticals submits board meeting intimation

USFDA completes cGMP inspection at Cipla’s arm’s New York facility

Cipla informs about updates

Ipca Laboratories informs about board meeting

Zydus Lifesciences rises as its arm partners with Prolific Machines

Zydus Lifesciences’ arm partners with Prolific Machines

Track Now:

All Indices

Nifty Healthcare Index FAQs

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Current Complaints

^ Average Resolution time is the sum total of time taken to resolve each complaint in days, in the current month divided by total number of complaints resolved in the current month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.

Nifty Healthcare Index Companies

News about Nifty Healthcare Index

Glenmark Pharmaceuticals submits board meeting intimation

USFDA completes cGMP inspection at Cipla’s arm’s New York facility

Cipla informs about updates

Ipca Laboratories informs about board meeting

Zydus Lifesciences rises as its arm partners with Prolific Machines

Zydus Lifesciences’ arm partners with Prolific Machines

Track Now:

Trending Blogs

All Indices

Nifty Healthcare Index FAQs

How to select the top Nifty Healthcare Index stocks based on RoE?

What are the best-performing stocks in the Nifty Healthcare Index index?

Which Nifty Healthcare Index stocks have the highest revenue growth in the past five years?

Which Nifty Healthcare Index stocks had the highest profit growth in the past five years ?

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.